Irina Liverko

39 ta ish

Tashkent Pediatric Medical Institute

1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyNew England Journal of Medicine20228 iqtibos

   ABIABI:AkademIndex/2022.article.000002

2. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/2021.article.000207

3. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

   Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyClinical Infectious Diseases20251 iqtibos

   ABIABI:AkademIndex/2025.article.000230

4. Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?

   Ruzilya Usmanova, Nargiza Parpieva, Hayk Davtyan +6

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

   ABIABI:AkademIndex/2026.other.262607

5. Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice

   Shahbosxon Akhmedov, Irina Liverko, Natalya Gafner +1

   MaqolaPneumocystis jirovecii pneumonia detection and treatment20170 iqtibos

   ABIABI:AkademIndex/2017.article.000869

6. Hypercoagulation as the main cause of death in COPD

   Elnorahon Abduganieva, Djahangir Artikov, Irina Liverko

   MaqolaVenous Thromboembolism Diagnosis and Management20190 iqtibos

   ABIABI:AkademIndex/2019.article.000622

7. [MYOCARDIAL INFARCTION IN THE PATIENTS WITH COPD: CAUSES, RISK FACTORS AND PATHOGENICAL LINK (REVIEW)].

   Irina Liverko, E Abduganiva

   MaqolaChronic Obstructive Pulmonary Disease (COPD) ResearchPubMed20190 iqtibos

   ABIABI:AkademIndex/2019.article.001878

8. Frequency, nature and risk factors of lesions of the esophagogastroduodenal zone in patients with bronchial asthma

   M. T. Rustamova, Irina Liverko, S. S. Khayrullaeva +1

   MaqolaOAOchiq kirishEosinophilic EsophagitisExperimental and Clinical Gastroenterology20200 iqtibos

   ABIABI:AkademIndex/2020.article.001655

9. Chronic obstructive pulmonary disease in organized groups

   Gulchekhra Tashmetova, Irina Liverko

   MaqolaOAOchiq kirishHealthcare Systems and Public HealthTuberculosis and lung diseases20200 iqtibos

   ABIABI:AkademIndex/2020.article.001666

10. Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy

    Irina Liverko

    MaqolaAntibiotic Use and Resistance20200 iqtibos

    ABIABI:AkademIndex/2020.article.003441

11. Взаимосвязь между полиморфизмом LYS198ASР гена Эндотелин-1 и хронической обструктивной болезнью легких у пациентов узбекской популяции

    Elnorahon Abduganieva, Irina Liverko, А.Т. Бобоев +2

    MaqolaOAOchiq kirish20200 iqtibos

    ABIABI:AkademIndex/2020.article.007825

12. Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +3

    MaqolaTuberculosis Research and Epidemiology20210 iqtibos

    ABIABI:AkademIndex/2021.article.002154

13. Inherited thrombophilia in the development of thrombotic conditions in patients with COPD

    Elnorahon Abduganieva, Irina Liverko, Kadirjon T. Boboev +1

    MaqolaBlood Coagulation and Thrombosis Mechanisms20210 iqtibos

    ABIABI:AkademIndex/2021.article.010132

14. Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +8

    MaqolaTuberculosis Research and Epidemiology20210 iqtibos

    ABIABI:AkademIndex/2021.article.010203

15. The phenotypes of chronic obstructive pulmonary disease with comorbidity of obstructive sleep apnea syndrome.

    Khayrillo Rajabov, Irina Liverko

    MaqolaChronic Obstructive Pulmonary Disease (COPD) Research20230 iqtibos

    ABIABI:AkademIndex/2023.article.011321

16. The forecast of the course of chronic obstructive pulmonary disease with obstructive-apnoea syndrome during sleep

    Khayrillo Rajabov, Irina Liverko

    MaqolaObstructive Sleep Apnea Research20230 iqtibos

    ABIABI:AkademIndex/2023.article.011322

17. COPD as a trigger for the development of thromboses in patients with defects in the genes predisposing to thrombosis

    Elnorahon Abduganieva, Irina Liverko

    MaqolaHuman Health and Disease20230 iqtibos

    ABIABI:AkademIndex/2023.article.011323

18. Community-acquired pneumonia: risk and prognosis

    Rano Nalibaeva, Irina Liverko

    MaqolaHealthcare Systems and Public Health20230 iqtibos

    ABIABI:AkademIndex/2023.article.011325

19. Medical errors in the use of antibacterial drugs of the cephalosporin group at the outpatient stage of the treatment of respiratory pathology

    Irina Liverko, Feruza Niyazova

    MaqolaHealthcare Systems and Public Health20230 iqtibos

    ABIABI:AkademIndex/2023.article.011326

20. Beta-lactamase activity is a biomarker for the prediction of the efficacy of antimicrobial therapy.

    Farkhod Mukhsinov, Irina Liverko

    MaqolaAntibiotic Use and Resistance20230 iqtibos

    ABIABI:AkademIndex/2023.article.011328

21. COVID-19 pandemic: challenges, facts and risks of antibiotic resistance

    Irina Liverko, Feruza Niyazova

    MaqolaAntibiotic Use and Resistance20230 iqtibos

    ABIABI:AkademIndex/2023.article.011329

22. Frequency of occurrence and gene-serotype characteristic of streptococcus pneumoniae in cohort of patients with COPD

    Rano Nalibaeva, Irina Liverko

    MaqolaPneumonia and Respiratory Infections20230 iqtibos

    ABIABI:AkademIndex/2023.article.011411

23. The impact of the COVID-19 pandemic on tuberculosis detection in Tashkent, Uzbekistan

    Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6

    MaqolaDiverse Scientific Research Studies20230 iqtibos

    ABIABI:AkademIndex/2023.article.011428

24. Patient-reported experiences and quality of life outcomes in the TB-PRACTECAL clinical trial: PRACTECAL-PRO

    Beverley Stringer, Karen Lowton, M. Cusinato +6

    BoshqaOAOchiq kirish20230 iqtibos

    ABIABI:AkademIndex/2023.other.001840

25. How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial

    Ilaria Motta, Martina Cusinato, Andrew Ludman +15

    MaqolaOAOchiq kirishCardiac electrophysiology and arrhythmiasAntimicrobial Agents and Chemotherapy20240 iqtibos

    ABIABI:AkademIndex/2024.article.000869